compliance and regulatory
Digitizing Compassionate Access Programs with Zelthy
Zelthy’s digital platform cut compassionate access approval times by 65%, lowered costs 40%, and made therapy access seamless and compliant in Australia.
Summary
A leading pharmaceutical company in Australia partnered with Zelthy to digitize and unify its Patient Support Programs (PSPs) for oncology therapies. The multi-PSP platform streamlined patient onboarding, enhanced therapy adherence, and reduced operational inefficiencies while ensuring full TGA compliance.
Key Outcomes:
45% increase in therapy adherence.
60% faster patient onboarding (cut enrollment time from 5 days to 2).
30% reduction in operational costs through automation.
85% of patients reported improved engagement and confidence in therapy.
Australia’s $4B oncology drugs market is growing rapidly but faces delays in patient access. With automated workflows, virtual consultations, and integrated data, Zelthy improved adherence by 45%, accelerated enrollment by 60%, and reduced operational costs by 30%, ensuring faster, more effective patient care.
Background
Australia’s booming $4B oncology drugs market faces a paradox- the rapid growth of cancer, paired with delays in delivering life-saving treatments. A leading pharmaceutical company in Australia partnered with Zelthy to develop a multi-PSP (Patient Support Program) platform that offered a personalized, end-to-end patient journey across multiple therapy areas.
The platform digitally enabled patient engagement and therapy adherence by integrating value-added services such as injection training, therapy reminders, video visits, and field visits. It supported healthcare professionals (HCPs), hospital staff, nurses, and patients, ensuring a seamless, compliant, and efficient experience.
With Zelthy’s configurable, low-code architecture, the pharma company streamlined patient onboarding, therapy management, and care coordination, reducing manual effort and enhancing adherence rates by 45%.
Challenges
Before implementing the Zelthy-powered PSP platform, the pharma company faced several challenges:
- Fragmented Patient Journeys: Different PSPs operated in silos, making it difficult to offer a consistent patient experience.
- Limited Engagement & Adherence: Patients often missed follow-ups, therapy schedules, and injections, leading to reduced treatment effectiveness.
- Operational Inefficiencies: Lack of an integrated system meant high administrative workloads for nurses, hospitals, and HCPs.
- No Real-Time Monitoring & Analytics: Pharma teams struggled to track program performance, patient adherence, and engagement metrics.
- Regulatory Compliance & Data Security Risks: Managing patient data across different PSPs required strict adherence to privacy regulations.
To improve patient outcomes, reduce drop-offs, and enhance therapy adherence, the company needed a unified, digital-first PSP platform that could support multiple patient journeys while ensuring regulatory compliance.
Solution: A Scalable, Multi-PSP Platform on Zelthy
The pharma company leveraged Zelthy’s healthcare platform to build a customized PSP solution with:
Personalized, Multi-PSP Patient Journeys
- Custom Patient Workflows for Each PSP: Patients were guided through tailored support programs based on their therapy.
- Automated Onboarding & Eligibility Verification: Faster registration reduced program enrollment time by 60%.
Value-Added Patient Services
- Therapy Adherence Reminders: Patients received automated SMS, email, and app notifications to reduce missed doses.
- Video Consultations & Virtual Visits: Enabled remote nurse consultations, reducing the need for hospital visits.
- Field Visit Coordination: Nurses could schedule in-home visits for injection training, therapy initiation, and adherence support.
- Patient Progress Tracking: Real-time adherence dashboards helped pharma teams monitor drop-off rates and therapy progress.
Role-Based Access for Seamless Collaboration
- HCP Portal: Doctors could monitor patient therapy progress, schedule interventions, and access treatment histories.
- Hospital & Nurse Portal: Nurses could track appointments, update patient status, and provide virtual or in-person support.
- Patient Portal: Patients could view therapy schedules, access resources, book appointments, and receive reminders.
Regulatory Compliance & Data Security
- Fully compliant with TGA (Therapeutic Goods Administration) regulations.
- End-to-end encryption & audit trails to ensure data privacy and security.
Key Outcomes & Impact
- 45% Increase in Patient Adherence: Automated reminders, virtual check-ins, and nurse support improved therapy completion rates.
- 60% Faster Patient Enrollment: Digital onboarding eliminated paperwork, reducing enrollment time from 5 days to 2 days.
- 30% Reduction in Operational Costs: Automation lowered administrative overhead, allowing PSP staff to focus on patient care.
- 85% of Patients Reported Improved Engagement: Personalized support enhanced patient confidence in managing their treatment.
- Real-Time Insights for Pharma Teams: Analytics dashboards provided actionable data on therapy adherence trends and patient engagement.
Conclusion
By adopting Zelthy’s multi-PSP digital platform, the pharmaceutical company successfully:
- Enhanced therapy adherence and patient engagement,
- Streamlined operations for PSP teams and healthcare providers, and
- Ensured compliance with regulatory standards.
With Zelthy’s flexible, low-code, and secure architecture, pharma companies can rapidly build PSP solutions that optimize patient outcomes while reducing operational complexity—setting a new benchmark for digital-first patient support in oncology care.
